ARMISTICE CAPITAL LLC 13D/13G Filings for Skye Bioscience, Inc. (SKYE)

ARMISTICE CAPITAL LLC 13D and 13G filings for Skye Bioscience, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
5:29 pm
Purchase
2020-12-3113GSkye Bioscience, Inc.
SKYE
ARMISTICE CAPITAL LLC50,413
4.990%
50,413increase
(New Position)
Filing